Viewing StudyNCT00142415



Ignite Creation Date: 2024-05-05 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00142415
Status: COMPLETED
Last Update Posted: 2022-10-28
First Post: 2005-08-31

Brief Title: Phase III Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer
Sponsor: Ludwig Institute for Cancer Research
Organization: Ludwig Institute for Cancer Research

Conditions & Keywords Data

Conditions:
Name
Metastatic Renal Cell Carcinoma
Keywords:
Name View
Advanced Renal Cell Carcinoma View
Clear Cell Renal Cell Carcinoma CCRCC View
Lutetium-177 View
177-Lu View
cG250 View
DOTA-cG250 View
Monoclonal Antibody View